Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 1 - 10 of 181

Selected Filters:
8 May 2026

PrEP Drug Interaction Checker

This website, developed and maintained by the University of Liverpool, provides clear, trustworthy, and up-to-date information about how different PrEP options, including oral PrEP, cabotegravir, lenacapavir, and the dapivirine vaginal ring, can interact with other drugs.

Research, Service Delivery

External Link
17 April 2026

Zambia PrEP Training Materials for Clinicians and Community Mobilisers

These materials, developed by Zambia’s Ministry of Health, can be used to train clinicians and mobilisers in delivery of PrEP methods, including injectable lenacapavir (LEN), cabotegravir (CAB), the dapivirine vaginal ring (DVR), the Dual Prevention Pill (DPP), and oral PrEP.

Normative Guidance/Policies, Service Delivery

Document
17 April 2026

Zambia Guidelines for Pre and Post-Exposure Prophylaxis for HIV Infection, 2025

These clinical guidelines, developed by Zambia’s Ministry of Health in 2025, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR), as well as the Dual Prevention Pill and oral PrEP.

Normative Guidance/Policies

Document
27 March 2026

HIV Prevention Ambassador Training Package and Toolkit

The HIV Prevention Ambassador Training Package and Toolkit is designed for community-based organizations and other groups to train HIV Prevention Ambassadors with the goal of promoting the meaningful engagement of communities and potential and current PrEP users in the rollout of oral PrEP for HIV prevention.

Community/Advocacy, Demand Creation/Marketing

Document
9 February 2026

Dapivirine Ring: Giving Women Hope and Choice in HIV Prevention

Recording / Transcript / Slides / Resources The monthly Dapivirine Vaginal Ring (DVR) is a critical option in the HIV prevention toolkit, being entirely woman controlled, discrete, and very safe and simple to implement. This webinar will highlight ongoing Market Access activities to ensure women have access to the monthly DVR; key learnings from community…

Community/Advocacy, Research, Service Delivery

Event
9 February 2026

PrEP Clinical Reporting Tools

This suite of clinical reporting forms, developed by South Africa’s National Department of Health, can be used for PrEP reporting, including injectable lenacapavir (LEN). The download folder includes forms for PrEP initiation, continuation, pregnancy outcome reporting, and seroconversion reporting.

Monitoring & Evaluation

Document
5 February 2026

GBGMC Country Profiles

These country profiles provide concise, actionable snapshots of the HIV prevention and treatment landscape for key populations across multiple countries, including: Brazil, Eswatini, France, Kenya, Malawi, Mozambique, Nigeria, the Philippines, South Africa, Uganda, Ukraine, the United States, Vietnam, Zambia, and Zimbabwe. Country profiles highlight: History of PrEP introduction Updates on PrEP Products Key population epidemiology…

Community/Advocacy, Demand Creation/Marketing, Monitoring & Evaluation, Normative Guidance/Policies, Service Delivery

External Link
13 January 2026

Integrated Study Dashboard

This dashboard, produced under the BioPIC project, reflects all currently known activities relating to implementation research, modelling, clinical research, and landscaping for new late stage biomedical HIV PrEP options, including lenacapavir for PrEP, cabotegravir, and the dapivirine vaginal ring. To update or add any activities missing from the dashboard, or if you have questions on…

Research

External Link
6 January 2026

Country Planning for Product Introduction Matrix

AVAC’s Country Planning for Product Introduction Matrix tracks key indicators for the introduction of new PrEP products, including lenacapavir (LEN), cabotegravir (CAB), and the Dapivirine Vaginal Ring (DVR), by country, including regulatory status, late stage clinical trials and implementation research, procurement plans, and recent oral PrEP provision.

Research, Service Delivery

External Link
3 November 2025

Consolidated Guidelines for the Prevention and Treatment of HIV and AIDS in Uganda, 2022

These guidelines, produced in 2022 by the Uganda Ministry of Health, provide guidance on the diagnosis of HIV, the care of people living with HIV, and the use of antiretroviral drugs for treating and preventing HIV infection, including injectable cabotegravir and the dapivirine vaginal ring.

Normative Guidance/Policies

Document